Old Port Advisors’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.06M Buy
16,332
+639
+4% +$84.2K 0.41% 74
2026
Q1
$2.19M Buy
15,693
+1,890
+14% +$265K 0.5% 69
2025
Q4
$1.69M Buy
13,803
+3,099
+29% +$377K 0.42% 75
2025
Q3
$1.19M Buy
10,704
+3,383
+46% +$385K 0.3% 100
2025
Q2
$812K Buy
+7,321
New +$779K 0.22% 122
2018
Q2
$323K Buy
+4,557
New +$322K 0.17% 129

Other funds holding GILD

Old Port Advisors's GILD Position: Q2 2026 in Review

Old Port Advisors increased its Gilead Sciences (GILD) stake by 4.1% in Q2 2026, buying an estimated $84.2K and bringing the position to 16,332 shares worth $2.06M. The position accounts for 0.41% of the portfolio, ranked #74.

Old Port Advisors first reported a position in GILD in Q2 2018 and has held it in 6 quarters since. The position peaked at $2.19M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Old Port Advisors held 16,332 shares of Gilead Sciences worth $2.06M as of Q2 2026.
  • Old Port Advisors bought 639 Gilead Sciences shares in Q2 2026, an estimated $84.2K.
  • Gilead Sciences made up 0.41% of Old Port Advisors's portfolio in Q2 2026, its #74 holding.
  • Old Port Advisors first reported a position in Gilead Sciences in Q2 2018 and has held it in 6 quarters since.
  • Old Port Advisors's Gilead Sciences position peaked at $2.19M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Old Port Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.